Source: Annual Congress 2006 - Outcomes of anti-tuberculosis treatment
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Faridian Eragh, S. Falah Tafti, M. Marashian, S. M. Mirsaeidi, M. Kazempoor Dizaji (Tehran, Islamic Republic Of Iran). Short outcome and evaluation of hemoptysis in patients with old pulmonary TB. Eur Respir J 2006; 28: Suppl. 50, 173

Member's Comments

No comment yet.

Related content which might interest you: Short term outcome of patients with advanced bronchiectasis and healed pulmonary tuberculosis from ICU Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 Prevalence of dyspnoea in patients with treated pulmonary tuberculosis Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Clinical characteristics and outcomes of patients with clinically unsuspected pulmonary embolism versus patients with clinically suspected pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004 Long term effect of bronchial arterial embolization in hemoptysis patients by pulmonary tuberculosis sequelae Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006 Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016 Year: 2017 Clinical presentation and outcome in pulmonary tuberculosis with diabetes about 39 cases Source: Annual Congress 2008 - Outcomes of tuberculosis treatment Year: 2008 Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015 Management appropriateness and outcomes of patients with acute pulmonary embolism Source: Eur Respir J, 51 (5) 1800445; 10.1183/13993003.00445-2018 Year: 2018 Using SF-36 in assessment of quality of life in patients cured of pulmonary tuberculosis Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Long-term follow-up of patients with pulmonary sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Cough improves earlier than sputum after treatment initiation in hospitalised patients with pulmonary tuberculosis Source: Virtual Congress 2020 – Tuberculosis and adverse events in different populations Year: 2020 Pulmonary rehabilitation outcome in COPD patients Source: Annual Congress 2003 - Outcome of pulmonary rehabilitation Year: 2003 The effect of pulmonary rehabilitation programme in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Rehabilitation, outcome measures and effects Year: 2011 Clinical profile and outcome of complicated pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 362s Year: 2002 Impact of a pulmonary rehabilitation program on psychopathology of patients diagnosed with COPD Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD Year: 2012 Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018 Year: 2018 Presence of bronchopulmonary shunting is an independent risk factor for recurrence of hemoptysis following bronchial artery embolization in younger patients with bronchiectasis: a long-term outcome Source: International Congress 2019 – Highlights in lung function and chronic cough Year: 2019 Neoplastic pulmonary lymphangitis and pulmonary hypertension: quality of life evaluation in 21 patients Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006 Impact of pulmonary tuberculosis on COPD outcomes Source: Virtual Congress 2021 – Advances in treatment and management of tuberculosis and nontuberculous mycobacterial disease Year: 2021